乳がんのプロテオゲノミクス・ランドスケープ 腫瘍発生と標的治療
Karsten Krug1, Eric J Jaehnig2, Shankha Satpathy1
1Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.
Cell
|November 19, 2020
まとめ
プロテオゲノミクスは タンパク質と遺伝データを統合して 乳がんの診断を精密にし 新しい治療戦略を特定します このアプローチは腫瘍の生物学と潜在的な治療目標の理解を高めます.
科学分野:
- 腫瘍学
- プロテオミクス
- ゲノミクス
背景:
- 乳がんは複雑な分子基盤を持つ異質的な悪性腫瘍です.
- 標準的な診断と治療方法では 腫瘍の生物学を完全に捉えることはできません
- マルチオミックスのデータを統合することで より包括的な腫瘍プロファイリング戦略が提供されます.
研究 の 目的:
- プロテオゲノミクスのアプローチを治療未経験の原発性乳がんに適用する.
- マススペクトロメトリーベースのプロテオミクスをDNAとRNAのシーケンシングと統合することで,腫瘍を包括的にプロファイルする.
- 乳がんの診断と治療の階層化を改善するためのプロテオゲノミクスの可能性を調査する.
主な方法:
- プロテオゲノミクスのアプローチを 122の治療未経験の原発性乳がんに適用した.
- タンパク質のリン酸化とアセチル化を含む翻訳後の修正が保存されています.
- 次世代DNAとRNAの配列解析による 統合された質量スペクトロメトリーベースのプロテオミクス
主要な成果:
- プロテオゲノミクスは標準的な乳がん診断に異議を唱え,ERBB2アンプリコンの詳細な分析を提供した.
- 免疫チェックポイント療法と,CDK4/ 6阻害剤反応に対するRb状態の評価の改善から潜在的に恩恵を受ける腫瘍サブセットを特定した.
- フォスフォプロテオミクスは,腫瘍抑制剤の喪失と標的化キナーゼとの間の新しい関連性を明らかにした.
- アセチルプロテオーム分析は,DNA損傷反応と代謝クロストークにおけるアセチル化を強調した.
結論:
- プロテオゲノミクスは 乳がんの臨床研究に 有力なアプローチを提供します
- この統合された戦略により,標的となる経路と生物学的特徴のより正確なアノテーションが可能になります.
- この発見は,乳がんの異質性に対処するプロテオゲノミクスの可能性を強調しています.
関連する概念動画
Targeted Cancer Therapies
8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.2K
mTOR Signaling and Cancer Progression
4.2K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.2K
Cancer-Critical Genes I: Proto-oncogenes
10.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Cancer
52.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
52.6K
Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K


